We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
-14.08%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$49.9B
AUM Growth
-$4.08B
(-7.6%)
Cap. Flow
+$2.86B
Cap. Flow
% of AUM
5.72%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
169
New
17
Increased
38
Reduced
75
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sony
SONY
|
+$614M |
| 2 |
American Express
AXP
|
+$273M |
| 3 |
Visa
V
|
+$168M |
| 4 |
Carlyle Group
CG
|
+$123M |
| 5 |
Lam Research
LRCX
|
+$88.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$265M |
| 2 |
Qualcomm
QCOM
|
+$202M |
| 3 |
PLAN
Anaplan, Inc.
PLAN
|
+$201M |
| 4 |
Microsoft
MSFT
|
+$181M |
| 5 |
Gartner
IT
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.76% |
| 2 | Consumer Discretionary | 8.03% |
| 3 | Financials | 5.66% |
| 4 | Communication Services | 3.69% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coinbase
COIN
$39.5B
| $81.6M | 0.16% |
429,865
-20,135
| -4% | -$3.93M |
|
|
102
CALL
Alibaba
BABA
$316B
| $81.6M | 0.16% |
750,000
-625,000
| -45% | -$72M |
|
103
CALL
Pinduoduo
PDD
$132B
| $80.2M | 0.16% |
+2,000,000
| New | +$103M |
|
104
Certara
CERT
$1.23B
| $75.7M | 0.15% |
3,523,667
-73,200
| -2% | -$1.76M |
|
|
BPMC
105
DELISTED
Blueprint Medicines
BPMC
| $73.1M | 0.15% |
1,143,899
-128,601
| -10% | -$9.23M |
|
106
Elastic
ESTC
$7.91B
| $70.6M | 0.14% |
794,168
-140,771
| -15% | -$12.6M |
|
|
CTLT
107
DELISTED
CATALENT, INC.
CTLT
| $70.3M | 0.14% |
634,345
+334,345
| +111% | +$34.9M |
|
108
KKR & Co
KKR
$92.8B
| $69.6M | 0.14% |
+1,190,728
| New | +$75M |
|
109
CoStar Group
CSGP
$12.5B
| $65.5M | 0.13% |
983,459
-1,286,990
| -57% | -$85.4M |
|
|
CERE
110
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $59.4M | 0.12% |
1,697,376
-211,659
| -11% | -$6.18M |
|
111
Full Truck Alliance
YMM
$10B
| $58.5M | 0.12% |
8,772,710
+2,459,242
| +39% | +$19.9M |
|
|
AVYA
112
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $57.8M | 0.12% |
4,561,041
-1,337,900
| -23% | -$20.8M |
|
113
Keros Therapeutics
KROS
$213M
| $49.3M | 0.1% |
906,433
-20,000
| -2% | -$1.03M |
|
114
Marqeta
MQ
$1.63B
| $46.3M | 0.09% |
1,048,762
+224,192
| +27% | +$10.4M |
|
115
GitLab
GTLB
$6.87B
| $40.1M | 0.08% |
736,206
+125,000
| +20% | +$7.46M |
|
|
AKRO
116
DELISTED
Akero Therapeutics
AKRO
| $34.3M | 0.07% |
2,419,671
-60,000
| -2% | -$1.05M |
|
117
Schrodinger
SDGR
$1.39B
| $33.6M | 0.07% |
984,812
+385,606
| +64% | +$11.7M |
|
118
PMV Pharmaceuticals
PMVP
$62.9M
| $33.3M | 0.07% |
1,599,553
| – | – |
|
119
CALL
KraneShares CSI China Internet ETF
KWEB
$5.75B
| $28.5M | 0.06% |
1,000,000
| – | – |
|
|
IGMS
120
DELISTED
IGM Biosciences
IGMS
| $27.6M | 0.06% |
1,034,035
+95,000
| +10% | +$1.77M |
|
121
JFrog
FROG
$10.7B
| $26.7M | 0.05% |
989,006
-148,992
| -13% | -$3.77M |
|
122
New Oriental
EDU
$9.16B
| $24.6M | 0.05% |
2,142,090
+325,514
| +18% | +$4.74M |
|
123
BioCryst Pharmaceuticals
BCRX
$2.45B
| $19.3M | 0.04% |
+1,187,845
| New | +$19.1M |
|
124
TG Therapeutics
TGTX
$7.53B
| $17.1M | 0.03% |
1,798,010
-70,291
| -4% | -$814K |
|
|
RNAM
125
DELISTED
Avidity Biosciences
RNAM
| $15.8M | 0.03% |
856,466
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Alkeon Capital Management held 169 positions worth $49.9B, down 7.6% from $54B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Alkeon Capital Management deployed $2.86B of net new capital in Q1 2022, opening 17 new positions and adding to 38 existing holdings. Its largest new stake was American Express: 1,512,619 shares worth $283M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Alibaba, an estimated $265M trimmed.
- Alkeon Capital Management's largest Q1 2022 buy was American Express: 1,512,619 shares worth $283M.
- Alkeon Capital Management added most to Sony in Q1 2022, an estimated $614M increase.
- Alkeon Capital Management's biggest Q1 2022 reduction was Alibaba, cutting an estimated $265M.
- Alkeon Capital Management fully exited Anaplan, Inc. in Q1 2022, selling an estimated $201M.
- Alkeon Capital Management's ten largest holdings make up 51% of its $49.9B portfolio in Q1 2022.
- Alkeon Capital Management opened 17 new positions and closed 24 in Q1 2022.
- Alkeon Capital Management's portfolio value fell 7.6% quarter-over-quarter to $49.9B.
Based on Alkeon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.